Nachum R
Prog Clin Biol Res. 1987;231:431-42.
LAL assay is a rapid and reliable and easy to perform and interpret urine screen for clinically significant gram-negative bacteriuria. Chromogenic assays are rapid (5 min) and obviate problems associated with gel endpoints, such as inadvertant dissolution of the gel, either during incubation or reading. LAL urine screening is characterized by both high positive and negative predictive values. LAL urine assay identifies gram-negative urinary tract infections by measuring urine endotoxin content as an index for significant numbers of urinary tract pathogens, thus eliminating large numbers of false-positive tests characteristic of other urine screening methods. Screening urine for greater than or equal to 10(5) CFU/ml appears to be an acceptable criterion for defining a UTI in patient populations with low prevalence rates (2-10%). Thus, LAL urine assay may have potential usefulness for screening of asymptomatic populations, such as pregnant women and the elderly.
鲎试剂检测法是一种快速、可靠且易于操作和解读的尿液筛查方法,用于检测临床上有意义的革兰氏阴性菌尿。显色检测法快速(5分钟),避免了与凝胶终点相关的问题,如在孵育或读数期间凝胶的意外溶解。鲎试剂尿液筛查的特点是具有较高的阳性和阴性预测值。鲎试剂尿液检测法通过测量尿液内毒素含量来识别革兰氏阴性尿路感染,以此作为大量尿路病原体的指标,从而消除了其他尿液筛查方法特有的大量假阳性检测。对于患病率较低(2 - 10%)的患者群体,筛查尿液中细菌浓度大于或等于10⁵CFU/ml似乎是定义尿路感染的可接受标准。因此,鲎试剂尿液检测法可能对无症状人群(如孕妇和老年人)的筛查具有潜在用途。